Global
Oncology Precision Medicine Market-2017-2027F
1.
Product Overview
2.
Research Methodology
3.
Executive Summary
4.
Impact of COVID-19 on Global Oncology Precision Medicine
Market
5.
Voice of Customer
5.1. Oncology Precision
Medicine Awareness
5.2. Cancer Prevalence,
By Gender
5.3. Cancer Prevalence,
By Age Group
5.4. Cancer Prevalence,
Region
5.5. Benefits of Using
Precision Medicine in Oncology
6.
Clinical Trial Analysis
7.
Patent Analysis
8. Global Oncology
Precision Medicine Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Ecosystem (Precision Diagnostics, Precision
Therapeutics, Applied Sciences, Digital Health, and Information Technology)
8.2.1.1.
Precision Diagnostics (Molecular Diagnostics v/s Medical
Imaging)
8.2.1.2.
Precision Therapeutics (Clinical Trials, Cell Therapy,
Drug Discovery & Research, Gene Therapy)
8.2.1.3.
Applied Sciences (Genomics, Pharmacogenomics, Others)
8.2.1.4.
Digital Health, and Information Technology (Clinical
Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics,
In-Silico Informatics, Others)
8.2.2.
By Application (Solid Tumor v/s Hematological
Malignancies)
8.2.2.1.
Solid Tumor (Breast Cancer, Lung Cancer, Colorectal
Cancer, Prostate Cancer, Others)
8.2.2.2.
Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin
Lymphoma, Leukemia, Others)
8.2.3. By
Region
8.2.4.
By Company (2021)
8.3.
Product Market Map
9. North America Oncology
Precision Medicine Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Ecosystem (Precision Diagnostics, Precision
Therapeutics, Applied Sciences, Digital Health, and Information Technology)
9.2.1.1.
Precision Diagnostics (Molecular Diagnostics v/s Medical
Imaging)
9.2.1.2.
Precision Therapeutics (Clinical Trials, Cell Therapy,
Drug Discovery & Research, Gene Therapy)
9.2.1.3.
Applied Sciences (Genomics, Pharmacogenomics, Others)
9.2.1.4.
Digital Health, and Information Technology (Clinical
Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics,
In-Silico Informatics, Others)
9.2.2.
By Application (Solid Tumor v/s Hematological
Malignancies)
9.2.2.1.
Solid Tumor (Breast Cancer, Lung Cancer, Colorectal
Cancer, Prostate Cancer, Others)
9.2.2.2.
Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin
Lymphoma, Leukemia, Others)
9.2.3.
By Country
9.3.
North America: Country Analysis
9.3.1.
United States Oncology Precision Medicine
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Ecosystem
9.3.1.2.2.
By Application
9.3.2.
Mexico Oncology Precision Medicine Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Ecosystem
9.3.2.2.2.
By Application
9.3.3.
Canada Oncology Precision Medicine Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Ecosystem
9.3.3.2.2.
By Application
10. Europe Oncology
Precision Medicine Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Ecosystem (Precision Diagnostics, Precision
Therapeutics, Applied Sciences, Digital Health, and Information Technology)
10.2.1.1.
Precision Diagnostics (Molecular Diagnostics v/s Medical
Imaging)
10.2.1.2.
Precision Therapeutics (Clinical Trials, Cell Therapy,
Drug Discovery & Research, Gene Therapy)
10.2.1.3.
Applied Sciences (Genomics, Pharmacogenomics, Others)
10.2.1.4.
Digital Health, and Information Technology (Clinical
Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics,
In-Silico Informatics, Others)
10.2.2.
By Application (Solid Tumor v/s Hematological
Malignancies)
10.2.2.1.
Solid Tumor (Breast Cancer, Lung Cancer, Colorectal
Cancer, Prostate Cancer, Others)
10.2.2.2.
Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin
Lymphoma, Leukemia, Others)
10.2.3.
By Country
10.3.
Europe: Country Analysis
10.3.1.
France Oncology Precision Medicine Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Ecosystem
10.3.1.2.2.
By Application
10.3.2.
Germany Oncology Precision Medicine Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Ecosystem
10.3.2.2.2.
By Application
10.3.3.
United Kingdom Oncology Precision Medicine
Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Ecosystem
10.3.3.2.2.
By Application
10.3.4.
Italy Oncology Precision Medicine Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Ecosystem
10.3.4.2.2.
By Application
10.3.5.
Spain Oncology Precision Medicine Market Outlook
10.3.5.1.
Market Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2.
Market Share & Forecast
10.3.5.2.1.
By Ecosystem
10.3.5.2.2.
By Application
11. Asia-Pacific Oncology
Precision Medicine Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Ecosystem (Precision Diagnostics, Precision
Therapeutics, Applied Sciences, Digital Health, and Information Technology)
11.2.1.1.
Precision Diagnostics (Molecular Diagnostics v/s Medical
Imaging)
11.2.1.2.
Precision Therapeutics (Clinical Trials, Cell Therapy,
Drug Discovery & Research, Gene Therapy)
11.2.1.3.
Applied Sciences (Genomics, Pharmacogenomics, Others)
11.2.1.4.
Digital Health, and Information Technology (Clinical
Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics,
In-Silico Informatics, Others)
11.2.2.
By Application (Solid Tumor v/s Hematological
Malignancies)
11.2.2.1.
Solid Tumor (Breast Cancer, Lung Cancer, Colorectal
Cancer, Prostate Cancer, Others)
11.2.2.2.
Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin
Lymphoma, Leukemia, Others)
11.2.3.
By Country
11.3.
Asia-Pacific: Country Analysis
11.3.1.
China Oncology Precision Medicine Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Ecosystem
11.3.1.2.2.
By Application
11.3.2.
India Oncology Precision Medicine Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Ecosystem
11.3.2.2.2.
By Application
11.3.3.
South Korea Oncology Precision Medicine
Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Ecosystem
11.3.3.2.2.
By Application
11.3.4.
Japan Oncology Precision Medicine Market Outlook
11.3.4.1.
Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2.
Market Share & Forecast
11.3.4.2.1.
By Ecosystem
11.3.4.2.2.
By Application
11.3.5.
Australia Oncology Precision Medicine Market Outlook
11.3.5.1.
Market Size & Forecast
11.3.5.1.1.
By Value
11.3.5.2.
Market Share & Forecast
11.3.5.2.1.
By Ecosystem
11.3.5.2.2.
By Application
12. South America Oncology
Precision Medicine Market Outlook
12.1.
Market Size & Forecast
12.1.1.
By Value
12.2.
Market Share & Forecast
12.2.1.
By Ecosystem (Precision Diagnostics, Precision
Therapeutics, Applied Sciences, Digital Health, and Information Technology)
12.2.1.1.
Precision Diagnostics (Molecular Diagnostics v/s Medical
Imaging)
12.2.1.2.
Precision Therapeutics (Clinical Trials, Cell Therapy,
Drug Discovery & Research, Gene Therapy)
12.2.1.3.
Applied Sciences (Genomics, Pharmacogenomics, Others)
12.2.1.4.
Digital Health, and Information Technology (Clinical
Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics,
In-Silico Informatics, Others)
12.2.2.
By Application (Solid Tumor v/s Hematological
Malignancies)
12.2.2.1.
Solid Tumor (Breast Cancer, Lung Cancer, Colorectal
Cancer, Prostate Cancer, Others)
12.2.2.2.
Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin
Lymphoma, Leukemia, Others)
12.2.3.
By Country
12.3.
South America: Country Analysis
12.3.1.
Brazil Oncology Precision Medicine Market Outlook
12.3.1.1.
Market Size & Forecast
12.3.1.1.1.
By Value
12.3.1.2.
Market Share & Forecast
12.3.1.2.1.
By Ecosystem
12.3.1.2.2.
By Application
12.3.2.
Argentina Oncology Precision Medicine Market Outlook
12.3.2.1.
Market Size & Forecast
12.3.2.1.1.
By Value
12.3.2.2.
Market Share & Forecast
12.3.2.2.1.
By Ecosystem
12.3.2.2.2.
By Application
12.3.3.
Colombia Oncology Precision Medicine Market Outlook
12.3.3.1.
Market Size & Forecast
12.3.3.1.1.
By Value
12.3.3.2.
Market Share & Forecast
12.3.3.2.1.
By Ecosystem
12.3.3.2.2.
By Application
13. Middle East and
Africa Oncology Precision Medicine Market Outlook
13.1.
Market Size & Forecast
13.1.1.
By Value
13.2.
Market Share & Forecast
13.2.1.
By Ecosystem (Precision Diagnostics, Precision
Therapeutics, Applied Sciences, Digital Health, and Information Technology)
13.2.1.1.
Precision Diagnostics (Molecular Diagnostics v/s Medical
Imaging)
13.2.1.2.
Precision Therapeutics (Clinical Trials, Cell Therapy,
Drug Discovery & Research, Gene Therapy)
13.2.1.3.
Applied Sciences (Genomics, Pharmacogenomics, Others)
13.2.1.4.
Digital Health, and Information Technology (Clinical
Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics,
In-Silico Informatics, Others)
13.2.2.
By Application (Solid Tumor v/s Hematological
Malignancies)
13.2.2.1.
Solid Tumor (Breast Cancer, Lung Cancer, Colorectal
Cancer, Prostate Cancer, Others)
13.2.2.2.
Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin
Lymphoma, Leukemia, Others)
13.2.3.
By Country
13.3.
MEA: Country Analysis
13.3.1.
South Africa Oncology Precision Medicine
Market Outlook
13.3.1.1.
Market Size & Forecast
13.3.1.1.1.
By Value
13.3.1.2.
Market Share & Forecast
13.3.1.2.1.
By Ecosystem
13.3.1.2.2.
By Application
13.3.2.
Saudi Arabia Oncology Precision Medicine
Market Outlook
13.3.2.1.
Market Size & Forecast
13.3.2.1.1.
By Value
13.3.2.2.
Market Share & Forecast
13.3.2.2.1.
By Ecosystem
13.3.2.2.2.
By Application
13.3.3.
UAE Oncology Precision Medicine Market Outlook
13.3.3.1.
Market Size & Forecast
13.3.3.1.1.
By Value
13.3.3.2.
Market Share & Forecast
13.3.3.2.1.
By Ecosystem
13.3.3.2.2.
By Application
14.
Market Dynamics
14.1.
Drivers
14.2.
Challenges
15.
Market Trends & Developments
16.
SWOT Analysis: Global Oncology Precision Medicine Market
17.
Competitive Landscape (Inclusive of SWOT Analysis of
Players Profiled)
17.1.
Novartis AG
17.2.
F. Hoffmann-La Roche AG
17.3.
Merck & Co., Inc.
17.4.
Danaher Corporation
17.5.
Abbott Laboratories, Inc.
17.6.
Quest Diagnostics Inc
17.7.
Eurofins Genomics LLC
17.8.
Laboratory Corporation of America Holdings
17.9.
Thermos Fischer Scientific, Inc.
17.10.
bioMérieux SA
18. Strategic Recommendations